Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

S. A. Long, M. Rieck, S. Sanda, J. B. Bollyky, P. L. Samuels, R. Goland, Andrew Ahmann, A. Rabinovitch, S. Aggarwal, D. Phippard, L. A. Turka, M. R. Ehlers, P. J. Bianchine, K. D. Boyle, S. A. Adah, J. A. Bluestone, J. H. Buckner, C. J. Greenbaum

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalDiabetes Technology and Therapeutics
Volume15
Issue numberSUPPL.1
DOIs
StatePublished - Jun 1 2013

Fingerprint

Sirolimus
Type 1 Diabetes Mellitus
Interleukin-2
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. / Long, S. A.; Rieck, M.; Sanda, S.; Bollyky, J. B.; Samuels, P. L.; Goland, R.; Ahmann, Andrew; Rabinovitch, A.; Aggarwal, S.; Phippard, D.; Turka, L. A.; Ehlers, M. R.; Bianchine, P. J.; Boyle, K. D.; Adah, S. A.; Bluestone, J. A.; Buckner, J. H.; Greenbaum, C. J.

In: Diabetes Technology and Therapeutics, Vol. 15, No. SUPPL.1, 01.06.2013.

Research output: Contribution to journalArticle

Long, SA, Rieck, M, Sanda, S, Bollyky, JB, Samuels, PL, Goland, R, Ahmann, A, Rabinovitch, A, Aggarwal, S, Phippard, D, Turka, LA, Ehlers, MR, Bianchine, PJ, Boyle, KD, Adah, SA, Bluestone, JA, Buckner, JH & Greenbaum, CJ 2013, 'Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function', Diabetes Technology and Therapeutics, vol. 15, no. SUPPL.1. https://doi.org/10.1089/dia.2013.1510
Long, S. A. ; Rieck, M. ; Sanda, S. ; Bollyky, J. B. ; Samuels, P. L. ; Goland, R. ; Ahmann, Andrew ; Rabinovitch, A. ; Aggarwal, S. ; Phippard, D. ; Turka, L. A. ; Ehlers, M. R. ; Bianchine, P. J. ; Boyle, K. D. ; Adah, S. A. ; Bluestone, J. A. ; Buckner, J. H. ; Greenbaum, C. J. / Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. In: Diabetes Technology and Therapeutics. 2013 ; Vol. 15, No. SUPPL.1.
@article{0488de39d1b14d1d85fa9b1bc38def5a,
title = "Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function",
author = "Long, {S. A.} and M. Rieck and S. Sanda and Bollyky, {J. B.} and Samuels, {P. L.} and R. Goland and Andrew Ahmann and A. Rabinovitch and S. Aggarwal and D. Phippard and Turka, {L. A.} and Ehlers, {M. R.} and Bianchine, {P. J.} and Boyle, {K. D.} and Adah, {S. A.} and Bluestone, {J. A.} and Buckner, {J. H.} and Greenbaum, {C. J.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1089/dia.2013.1510",
language = "English (US)",
volume = "15",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "SUPPL.1",

}

TY - JOUR

T1 - Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

AU - Long, S. A.

AU - Rieck, M.

AU - Sanda, S.

AU - Bollyky, J. B.

AU - Samuels, P. L.

AU - Goland, R.

AU - Ahmann, Andrew

AU - Rabinovitch, A.

AU - Aggarwal, S.

AU - Phippard, D.

AU - Turka, L. A.

AU - Ehlers, M. R.

AU - Bianchine, P. J.

AU - Boyle, K. D.

AU - Adah, S. A.

AU - Bluestone, J. A.

AU - Buckner, J. H.

AU - Greenbaum, C. J.

PY - 2013/6/1

Y1 - 2013/6/1

UR - http://www.scopus.com/inward/record.url?scp=84896846588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896846588&partnerID=8YFLogxK

U2 - 10.1089/dia.2013.1510

DO - 10.1089/dia.2013.1510

M3 - Article

AN - SCOPUS:84896846588

VL - 15

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - SUPPL.1

ER -